Hall, I H <br/><br/>
Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones.  [electronic resource] 

 -  Archiv der Pharmazie  Apr 2001 
 - 109-16 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0365-6233 
<br/><br/><label>Standard No.: </label>10.1002/1521-4184(200104)334:4<109::aid-ardp109>3.0.co;2-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>IMP Dehydrogenase--antagonists & inhibitors<br/>Isoenzymes--antagonists & inhibitors<br/>Leukemia-Lymphoma, Adult T-Cell--drug therapy